Immune adverse events of checkpoint inhibitors

Показать описание

Bernardo Rapoport, MD and Ronwyn Van Eeden MBChB, FCP(SA) of The Medical Oncology Centre of Rosebank, Johannesburg, South Africa discuss immune-related side effects associated with checkpoint inhibitors. Dr Rapoport says that checkpoint inhibitors have been a major breakthrough in the management of malignant melanoma and non-small cell lung cancer. New checkpoint inhibitors are used to treat triple-negative breast cancer, blood cancer, ovarian and gastric cancer. Dr Van Eededn mentions that it is a new therapy with a different mechanism of action and side effect profile than chemotherapy or targeted therapies. Dr Rapoport and dr Van Eeden talk about anti-CLTA-4 and anti-PD-1 antibody toxicities and point out that the combination of these two antibodies is associated with potentiation of toxicities. Recorded at the Multinational Association of Supportive Care in Cancer (MASCC) and International Society of Ocular Oncology (ISOO) 2016 Annual Meeting on Supportive Care in Cancer held in Adelaide, Australia.

Рекомендации по теме

Immune adverse events of checkpoint inhibitors

Immune adverse events of checkpoint inhibitors

Managing the adverse events of immune checkpoint inhibitors

Neurological adverse events associated with immune checkpoint inhibitors

Cancer Immune Checkpoint Inhibitors

Immune-related Adverse Events of Immune Checkpoint Inhibitors: What Emerg Phys Need to Know 25Mar21

Adverse effects of immune checkpoint inhibitors

Immune-related adverse events due to checkpoint inhibitors

Neuroimmunological adverse events associated with immune checkpoint inhibitors

SITC clinical practice guidelines on immune checkpoint inhibitor-related adverse events

Oral manifestations of immune-related adverse events in checkpoint inhibitor treatment

Side effects of immune checkpoint inhibitors

SITC clinical practice guidelines on immune checkpoint inhibitor-related adverse events

Correlation between cutaneous immune-related adverse events and OS with immune checkpoint inhibitors

Checkpoint inhibitors: monitoring and management of imAEs - video abstract ID 141577

Immune Related Adverse Effects Among Elderly Patients With Melanoma Treated W/ Checkpoint Inhibitors

Dr. Cassie Calabrese on Checkpoint therapy adverse events

Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in GU Cancers

Managing toxicities associated with immune-checkpoint inhibitors

Immune Checkpoint Inhibitor Related Kidney Adverse Events

Immune checkpoint inhibitors: recent progress and potential biomarkers - 1v Introduction

Immune Checkpoint Inhibition in Myeloid Malignancies

Immune Checkpoint Inhibitor Toxicities in the ICU: A review - SJHH Medical Grand Rounds

Immune Checkpoint Inhibitors: The Good, the Bad, and the Emerging Field of Cardio-Oncology

Managing Thyroid Adverse Events From Checkpoint Inhibitors